Insilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up

SK Biopharmaceuticals Co

22/06/2026 07:13

** Shares of Insilico Medicine Cayman TopCo 3696.HK jump 8.5% to HK$41.58, their highest point since June 1
** On track for a third straight session of gain 
** AI developer in pharmaceuticals enters into research and development collaboration with SK Biopharmaceuticals 326030.KS to discover AI-enabled innovative drug candidates in neuroimmune area of central nervous system
** Says it will be eligible to receive up to $18 mln in upfront and near-term milestone payments and total potential deal value exceeds $2.5 bln, including development, regulatory, and commercial milestone payments 
** YTD, stock up 9.3%, while the Hang Seng Biotech Index .HSBIO down 16.6%

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))